BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Discovery Life Sciences and Mindpeak Partner to Bring AI Precision to Cancer Biomarker Testing in Global Clinical Trials

  March 24, 2026

   · 

  4 min read
• Press Releases

  Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study

  March 24, 2026

   · 

  4 min read
• Press Releases

  SK pharmteco and Prozomix Announce Strategic Collaboration to Enhance Biocatalysis Capabilities for Global Drug Manufacturing

  March 24, 2026

   · 

  3 min read
• Press Releases

  Hoth Therapeutics Reports Positive HT-001 PK, Safety, and Clinical Activity Data in Cancer Patients with EGFR Therapy-Associated Skin Toxicities Showing ~77% Increase in Drug Exposure and Minimal Systemic Absorption

  March 24, 2026

   · 

  6 min read
• Press Releases

  HKeyBio Launches HKEY-NHP-onChip™ 1.1: World’s First NHP In Vitro Model for Autoimmune and Allergic Diseases

  March 24, 2026

   · 

  6 min read
• Press Releases

  Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review

  March 24, 2026

   · 

  6 min read
• Press Releases

  VIPER Diagnostics Program Launches as First Phase of PolyBio Long COVID Cure Initiative

  March 24, 2026

   · 

  3 min read
• Press Releases

  ISBRG Selected for Mayo Clinic and ASU Health Care Accelerator

  March 24, 2026

   · 

  3 min read
• Press Releases

  LucyRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2026

  March 24, 2026

   · 

  2 min read
• Press Releases

  NImmune Biopharma to Present Novel Mechanistic, Efficacy and Translational Data on LANCL2-Targeting Therapeutics Supporting Significant Pipeline-in-a-Drug Potential at IMMUNOLOGY2026

  March 24, 2026

   · 

  5 min read